Dr. Mansouri has a long-standing interest in the pathogenesis, prevention, and treatment of device-associated infections with a concentration in the development of novel means to avert these infections, which remain a medical challenge and can lead to excessive morbidity, undue mortality, and increased healthcare costs. Dr. Mansouri is also interested in new classes of small antimicrobial agents with novel non-traditional mechanisms of action that could evade resistance pathways.
